199 related articles for article (PubMed ID: 30187005)
1. Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1.
Feyissa AM; Lamb C; Pittock SJ; Gadoth A; McKeon A; Klein CJ; Britton JW
Epilepsia Open; 2018 Sep; 3(3):348-356. PubMed ID: 30187005
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
Li Y; Song F; Liu W; Wang Y
Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
5. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
6. Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis.
Li TR; Zhang YD; Wang Q; Shao XQ; Lv RJ
CNS Neurosci Ther; 2021 Oct; 27(10):1173-1181. PubMed ID: 34291554
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drug therapy in patients with autoimmune epilepsy.
Feyissa AM; López Chiriboga AS; Britton JW
Neurol Neuroimmunol Neuroinflamm; 2017 Jul; 4(4):e353. PubMed ID: 28680914
[TBL] [Abstract][Full Text] [Related]
8. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
[TBL] [Abstract][Full Text] [Related]
9. Faciobrachial motor seizures: A more apt description?
Muthusamy S; Foroush NC; Seneviratne U
Epilepsy Behav Rep; 2021; 16():100476. PubMed ID: 34505053
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
11. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
12. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
Irani SR; Michell AW; Lang B; Pettingill P; Waters P; Johnson MR; Schott JM; Armstrong RJ; S Zagami A; Bleasel A; Somerville ER; Smith SM; Vincent A
Ann Neurol; 2011 May; 69(5):892-900. PubMed ID: 21416487
[TBL] [Abstract][Full Text] [Related]
13. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
14. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
15. Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology.
Dubey D; Alqallaf A; Hays R; Freeman M; Chen K; Ding K; Agostini M; Vernino S
JAMA Neurol; 2017 Apr; 74(4):397-402. PubMed ID: 28166327
[TBL] [Abstract][Full Text] [Related]
16. LGI1-negative faciobrachial dystonic-like seizures originating from the insula.
Patira R; Khatri V; Gutierrez C; Zubkov S
Epilepsy Behav Case Rep; 2016; 6():33-5. PubMed ID: 27489774
[TBL] [Abstract][Full Text] [Related]
17. Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
Naasan G; Irani SR; Bettcher BM; Geschwind MD; Gelfand JM
JAMA Neurol; 2014 Oct; 71(10):1300-4. PubMed ID: 25133690
[TBL] [Abstract][Full Text] [Related]
18. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
Li LH; Ma CC; Zhang HF; Lian YJ
Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
[TBL] [Abstract][Full Text] [Related]
19. A feline model of spontaneously occurring autoimmune limbic encephalitis.
Glantschnigg-Eisl U; Klang A; Kneissl S; Lang B; Waters P; Irani SR; Binks SNM; Pakozdy A
Vet J; 2023; 296-297():105974. PubMed ID: 36958405
[TBL] [Abstract][Full Text] [Related]
20. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures.
Flanagan EP; Kotsenas AL; Britton JW; McKeon A; Watson RE; Klein CJ; Boeve BF; Lowe V; Ahlskog JE; Shin C; Boes CJ; Crum BA; Laughlin RS; Pittock SJ
Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e161. PubMed ID: 26468474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
